Cancer diagnostics company using genomics analysis raising $1.3 million
Genomics-based cancer diagnostics company RedPath Integrated Pathology is raising $1.3 million in fresh capital.
Genomics-based cancer diagnostics company RedPath Integrated Pathology is raising $1.3 million in fresh capital.
In 2002, drug maker GlaxoSmithKline sent one of its quality-assurance managers to Puerto Rico to help clean up a mess at one of its biggest manufacturing plants. Cheryl Eckard's journey ended this week with the largest ever U.S. whistleblower award -- at least $96 million, the Wall Street Journal reports.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.